Tuberous sclerosis complex Esclerose tuberosa

被引:15
|
作者
Rodrigues, Daniela Araujo [1 ]
Gomes, Ciro Martins [1 ]
Carvalho Costa, Izelda Maria [1 ]
机构
[1] Univ Brazilia UNB HUB, Univ Hosp Brazilia, BR-70910900 Brasilia, DF, Brazil
关键词
Dermatology; Diagnosis; Neurology; Sirolimus; Tuberous sclerosis; CONSENSUS CONFERENCE; MUTATIONAL ANALYSIS; MTOR; TSC1; DISEASE; LOCALIZATION; INACTIVATION; MOSAICISM; SIROLIMUS; SEVERITY;
D O I
10.1590/S0365-05962012000200001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tuberous Sclerosis Complex, also known as Epiloia or Bourneville-Pringle disease is an autosomal dominant neurocutaneous syndrome with variable clinical expression. It is a multisystem disorder that may be associated with hamartomas in multiple organs in an unpredictable manner. The dermatologist plays an essential role in the history of the disease, since skin manifestations represent the most prevalent clinical features, enabling early diagnosis and intervention in its natural course. This article aims to inform the scientific community about advances made in the study of genetics and molecular biology. Recent findings regarding stimulation of tumor growth have been changing the history of this condition, making therapeutic trials with topical and systemic drugs possible. Knowledge of these topics enables better management of the patients affected, since tissue replacement by tumors can result in significant morbidity and mortality.
引用
收藏
页码:184 / 194
页数:11
相关论文
共 50 条
  • [21] Early Neurodevelopmental Screening in Tuberous Sclerosis Complex: A Potential Window of Opportunity
    Gipson, Tanjala T.
    Gerner, Gwendolyn
    Srivastava, Siddharth
    Poretti, Andrea
    Vaurio, Rebecca
    Hartman, Adam
    Johnston, Michael V.
    PEDIATRIC NEUROLOGY, 2014, 51 (03) : 398 - 402
  • [22] Nursing Implications for the Lifelong Management of Tuberous Sclerosis Complex
    Agricola, Karen
    Tudor, Cindy
    Krueger, Darcy
    Franz, David Neal
    JOURNAL OF NEUROSCIENCE NURSING, 2013, 45 (04) : 226 - 242
  • [23] Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex
    Krueger, Darcy A.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2013, 15 (05) : 618 - 633
  • [24] Tuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth
    Jenkins, David
    McCuaig, Catherine
    Drolet, Beth A.
    Siegel, Dawn
    Adams, Susan
    Lawson, John A.
    Wargon, Orli
    PEDIATRIC DERMATOLOGY, 2016, 33 (05) : 536 - 542
  • [25] Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
    Salussolia, Catherine L.
    Klonowska, Katarzyna
    Kwiatkowski, David J.
    Sahin, Mustafa
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019, 2019, 20 : 217 - 240
  • [26] Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions
    Racioppi, Giacomo
    Checchi, Martina Proietti
    Sforza, Giorgia
    Voci, Alessandra
    Mazzone, Luigi
    Valeriani, Massimiliano
    Moavero, Romina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [27] Tuberous sclerosis complex, mTOR, and the kidney: report of an NIDDK-sponsored workshop
    Henske, Elizabeth P.
    Rasooly, Rebekah
    Siroky, Brian
    Bissler, John
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 306 (03) : F279 - F283
  • [28] Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex
    Darcy A. Krueger
    Current Treatment Options in Neurology, 2013, 15 : 618 - 633
  • [29] The cutaneous manifestations of tuberous sclerosis complex
    Nguyen, Quoc-Bao D.
    DarConte, Mary D.
    Hebert, Adelaide A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2018, 178 (03) : 321 - 325
  • [30] Tuberous sclerosis complex: the past and the future
    De Waele, Liesbeth
    Lagae, Lieven
    Mekahli, Djalila
    PEDIATRIC NEPHROLOGY, 2015, 30 (10) : 1771 - 1780